Alcohol Consumption-Related Metabolites in Relation to Colorectal Cancer and Adenoma: Two Case-Control Studies Using Serum Biomarkers.

Abstract

Alcohol is a known carcinogen that may be associated with colorectal cancer. However, most epidemiologic studies assess alcoholic beverage consumption using self-reported data, leading to potential exposure misclassification. Biomarkers of alcohol consumption may provide an alternative, complementary approach that reduces misclassification and incorporates individual differences in alcohol metabolism. Therefore, we evaluated the relationship between previously identified alcohol consumption-related metabolites and colorectal cancer and adenoma using serum metabolomics data from two studies. Data on colorectal cancer were obtained from a nested case-control study of 502 US adults (252 cases, 250 controls) within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Data on colorectal adenoma were obtained from a case-control study of 197 US adults (120 cases, 77 controls) from the Navy Colon Adenoma Study. Unconditional multivariable logistic regression models were fit to calculate odds ratios (OR) and 95% confidence intervals (CI) for eight alcohol consumption-related metabolites identified in a previous analysis: ethyl glucuronide; 4-androstene-3beta,17beta-diol disulfate 1; 5-alpha-androstan-3beta,17beta-diol disulfate; 16-hydroxypalmitate; bilirubin (E,Z or Z,E); cyclo (-leu-pro); dihomo-linoleate (20:2n6); and palmitoleate (16:1n7). We found no clear association between these alcohol consumption-related metabolites and either endpoint. However, we did observe an inverse association between cyclo (-leu-pro) and colorectal adenoma that was only observed in the highest metabolite quantile (OR 4th vs. 1st Quantile = 0.30, 95% CI: 0.12-0.78; P-trend = 0.047), but no association for colorectal cancer. In conclusion, there were no adverse associations between alcohol consumption-related metabolites and colorectal cancer or adenoma.

• Authors: Jose Ramon Troche, Susan T Mayne, Neal D Freedman, Fatma M Shebl, Kristin A Guertin, Amanda J Cross, Christian C Abnet
• Journal: PloS one (PLoS One) Vol. 11 Issue 3 Pg. e0150962 ( 2016) ISSN: 1932-6203 [Electronic] United States
• PMID: 26967509 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Intramural)

Chemical References

• Biomarkers
• Dipeptides
• Fatty Acids, Monounsaturated
• Glucuronates
• Palmitic Acids
• Peptides, Cyclic
• cyclo(leucyl-prolyl)
• ethyl glucuronide
• palmitoleic acid
• Androstane-3,17-diol
• Ethanol
• 16-hydroxypalmitic acid
• androstane-3,7-diol disulfate
• Linoleic Acid
• Bilirubin

Topics

• Adenoma (blood)
• Aged
• Alcohol Drinking (adverse effects)
• Alcoholic Beverages (adverse effects)
• Androstane-3,17-diol (analogs & derivatives, blood)
• Bilirubin (blood)
• Biomarkers (blood)
• Case-Control Studies
• Colorectal Neoplasms (blood)
• Dipeptides (blood)
• Ethanol (metabolism)
• Fatty Acids, Monounsaturated (blood)
• Female
• Glucuronates (blood)
• Humans
• Linoleic Acid (blood)
• Male
• Middle Aged
• Odds Ratio
• Palmitic Acids (blood)
• Peptides, Cyclic (blood)